88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

HkeyBio Launches "NHP Fast-PoC" Program to Deliver Low-Cost Cyno PK/PD and Developability Data Amid Rising NHP Prices The cost-effective platform delivers rapid pharmacological validation data in cynomolgus monkeys, helping biotech firms make confident R&D decisions before committing to full-scale IND studies. ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
QingSong Health Corp (2661.HK) and Basel Medical Sign Strategic Cooperation Memorandum to Explore AI Healthcare Services in Southeast Asia BEIJING , June 10, 2026 /PRNewswire/ -- Recently, QingSong Health Corp (2661.HK) and Basel Medical Group Ltd announced the signing of a Memorandum of Strategic Cooperation. The two parties intend ... 2026-06-10T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Vatech Completes Full-Portfolio EU MDR Certification Certification covers all three dental imaging categories and every 2026 model launch ... 2026-06-10T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board ... 2026-06-10T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Alteogen Showcases ALT-B4's Potential to Transform ADC Development at World ADC Summit 2026 Preclinical data demonstrate enhanced systemic exposure and bioavailability, reduced dermal toxicity, and improved safety profile in ALT-B4-enabled ADC therapy ... 2026-06-10T Health Care/Hospital Medical/Pharmaceuticals
Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders Partnership will combine n-Lorem's cutting-edge antisense oligonucleotide (ASO) technology and Servier's R&D expertise with the aim of advancing ASO technology and delivering precision medicine ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target BOSTON and SHENZHEN, China , June 10, 2026 /PRNewswire/ -- XtalPi (2228.HK), a leading platform in artificial intelligence (AI) and robotics-driven drug discovery, today announced a strategic partnership ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China SHANGHAI and HONG KONG , June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited ( "Antengene" , SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor HANGZHOU, China, SHANGHAI and BOSTON , June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on ... 2026-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved